Dengue and yellow fever--challenges for the development and use of vaccines.
Kleiner Perkins Caulfield & Byers, Menlo Park, CA, USA.
Thomas P
TP
Monath
D000818:Animals; D003715:Dengue / Q000453:epidemiology / Q000276:immunology / Q000517:prevention & control*; D053059:Dengue Vaccines; D003716:Dengue Virus / Q000472:pathogenicity / Q000648:ultrastructure; D006801:Humans; D007303:Insect Vectors; D012703:Serotyping; D019595:Severe Dengue / Q000453:epidemiology / Q000276:immunology; D014613:Vaccines, Attenuated; D015004:Yellow Fever / Q000453:epidemiology / Q000517:prevention & control*; D022341:Yellow Fever Vaccine / Q000009:adverse effects; D015005:Yellow fever virus
D053059:Dengue Vaccines; D014613:Vaccines, Attenuated; D022341:Yellow Fever Vaccine